https://stock.noler.com/us/stock/tc-biopharm-holdings-plc https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accounts-payable https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accounts-payable-other-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accounts-payable-trade-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accruals-classified-as-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accrued-liabilities-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accumulated-depreciation https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/accumulated-depreciation-depletion-and-amortization-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/additional-paid-in-capital https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjusted-weighted-average-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-current-tax-of-prior-period https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-decrease-increase-in-trade-account-receivable https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-depreciation-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-finance-costs https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-increase-decrease-in-deferred-income-including-contract-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-share-based-payments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/adjustments-for-unrealised-foreign-exchange-losses-gains https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/administrative-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/amended-reports https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/amortization https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/applicable-tax-rate https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/asset-impairment-charges https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/auditor https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/authorized-dilution https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/average-exercise-price-of-share-options-exercisable-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/average-exercise-price-of-share-options-forfeited-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/bank-borrowings-undiscounted-cash-flows https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/basic-earnings-loss-per-share https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/basic-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/beta https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/borrowing-costs-capitalised https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/borrowing-debt https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/borrowings-interest-rate https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/buybacks-repurchase-programs https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/capital-expenditures https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-and-cash-equivalents https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-and-equivalents https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-and-restricted-cash https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-and-securities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-fdic-insured-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-flow-breakdown https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-flows-from-used-in-operations https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-outflow-for-leases https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-receipts-from-repayment-of-advances-and-loans-made-to-other-parties-classified-as-investing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cash-uninsured-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/clinical-trials https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/common-stock-value https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/congressional-trades https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/convertible-debt https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/convertible-debt-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/convertible-notes-payable https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/convertible-securities-outstanding https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/convertible-securities-retired https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cost-of-goods-and-services-sold-amortization https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-assets-ifrs-full https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-contract-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-derivative-financial-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-lease-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-liabilities-ifrs-full https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-payables-on-social-security-and-taxes-other-than-income-tax https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-prepayments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-tax-assets-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-tax-expense-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/current-value-added-tax-receivables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/customer-breakdown https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/debt-convertible-conversion-price https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/decrease-through-classified-as-held-for-sale-property-plant-and-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-finance-costs-net https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-tax-assets-gross https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-tax-expense-income-relating-to-tax-rate-changes-or-imposition-of-new-taxes https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/deferred-tax-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/depreciation https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/derivative-financial-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/derivative-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/derivative-liabilities-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/description-of-expected-volatility-share-options-granted https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/description-of-risk-free-interest-rate-share-options-granted https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/diluted-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/dilutive-effect-of-convertible-instruments-on-number-of-ordinary-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/dilutive-effect-of-share-options-on-number-of-ordinary-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/directors-remuneration-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/dividend-safety https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/earnings-and-revenue-growth https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/ebitda https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/effective-interest-rate-of-financial-assets-reclassified-out-of-available-for-sale-financial-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/employee-benefits-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/eps https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/eps-basic https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/equity https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/equity-and-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-pay-measures https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-pay-other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-pay-pvp https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-before-2006 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-board https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-equity-awards https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-officers https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-other-compensation https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-other-mentions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-pay-ratio https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/executive-salary-relatives https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/exercise-price-of-outstanding-share-options-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/exercise-price-share-options-granted-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/expected-dividend-as-percentage-share-options-granted https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/expense-from-share-based-payment-transactions-in-which-goods-or-services-received-did-not-qualify-for-recognition-as-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/fails-to-deliver https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/fee-and-commission-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/finance-costs https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/finance-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/finance-lease-interest-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/financial-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/financing-cash-flow https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/foreign-currency-transaction-gain-loss-after-tax https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/foreign-exchange-loss https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/foreign-pretax-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/form-d-other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/free-cash-flow https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/gains-losses-arising-from-sale-and-leaseback-transactions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/gains-losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/gains-losses-on-exchange-differences-on-translation-recognised-in-profit-or-loss https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/general-and-administrative-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/gross-margin https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/holders-breakdown https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/income-tax https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/income-tax-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/income-taxes-paid-refund-classified-as-operating-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-cash-and-cash-equivalents https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-loans-deferred-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-number-of-shares-outstanding https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-in-prepaid-interest https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-through-net-exchange-differences-deferred-tax-liability-asset https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-holders https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-preferred https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-stock-options https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-stock-units https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-warrants https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/institutional-holders https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/interest-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/interest-expense-nonoperating https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/interest-expense-on-lease-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/interest-paid-classified-as-operating-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/interest-received-classified-as-operating-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/investing-cash-flow https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/iran-activity-notices https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/issue-of-equity https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/issued-capital https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/key-management-personnel-compensation https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/key-management-personnel-compensation-shortterm-employee-benefits https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/late-filing-notices https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/lawsuits-defendant https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/lawsuits-plaintiff https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/lease-cost https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/lease-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/loans-payable-in-default https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/long-term-debt-average-amount-outstanding https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/losses-on-disposals-of-property-plant-and-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/major-holders https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/material-contracts https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/mentioned-by-other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/mutual-fund-holders https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/net-change-in-cash https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/net-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/news https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/noncurrent-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/noncurrent-lease-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/noncurrent-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/notes-and-debentures-issued https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/notional-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-employees https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-operating-segments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-outstanding-share-options https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-shares-issued https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/number-of-shares-outstanding https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/obligation-breakdown https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-cash-flow https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-expenses https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-liability https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-liability-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-payments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-loss-carryforwards https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/operating-margin https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-current-payables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-current-receivables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-expenses https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-gains-losses https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-income-ifrs-full https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-inflows-outflows-of-cash-classified-as-operating-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-noncash-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-nonoperating-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-operating-income-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-payables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-prepaid-expense-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-receivables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-receivables-net-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/other-reserves https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/outstanding-bonds https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/outstanding-bonds-foreign https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/outstanding-bonds-matured https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/par-value-per-share https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/patents https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/patents-active https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/patents-expired https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/patents-pending https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/patents-rejected https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/payables-and-obligations https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/pb-ratio https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/pe-ratio https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/postemployment-benefit-expense-defined-contribution-plans https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/preferred-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/preferred-shares-facts https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/pretax-income https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/pretax-income-domestic https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-issuing-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-sales-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-stock-issued https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/profit-loss https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/profit-loss-before-tax https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/profit-loss-from-operating-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/property-plant-and-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/property-plant-and-equipment-additions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/property-plant-equipment https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/ps-ratio https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/public-float https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/purchase-of-intangible-assets-classified-as-investing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/quick-ratio https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/reddit https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/repayments-of-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/repayments-of-convertible-debt https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/repayments-of-subordinated-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/research-and-development https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/research-and-development-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/retained-earnings https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/retained-earnings-ifrs-full https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/revenue https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/revenue-from-contracts-with-customers https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/revenue-from-sale-of-goods-related-party-transactions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/revenue-ifrs-full https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/rightofuse-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/sec-comment-letters https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/sec-enforcement-actions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/sec-filings https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/share-buybacks https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/share-issue-related-cost https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/share-premium https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/share-price https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shareholder-equity https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shareholders-equity https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shares-authorized https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shares-issued https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shares-issued-2 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shares-issued-price-per-share https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/shares-outstanding-analysis https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/short-interest https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/short-sale-volume https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/social-security-contributions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/spending-and-interest-coverage https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-based-compensation https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/subsidiaries https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/supplier-breakdown https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-effect-of-expense-not-deductible-in-determining-taxable-profit-tax-loss https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-reconciliation-deductions https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/total-assets https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/total-liabilities https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/trade-and-other-current-payables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/trade-and-other-current-payables-to-trade-suppliers https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/trade-and-other-current-receivables https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/trade-and-other-payables-to-trade-suppliers https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/trade-and-other-payables-undiscounted-cash-flows https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/undiscounted-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/value-added-tax-receivable https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/value-added-tax-receivable-current https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/voting-outcome https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/wages-and-salaries https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/warrant-exercise-price-decrease https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/warrant-exercise-price-increase https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/weighted-average-lessees-incremental-borrowing-rate-applied-to-lease-liabilities-recognised-at-date-of-initial-application-of-ifrs-16 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/weighted-average-share-price-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/weighted-average-share-price-share-options-granted-2019 https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/weighted-average-shares https://stock.noler.com/us/stock/tc-biopharm-holdings-plc/youtube